Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06208007 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Arterial Stiffening as a Predictor for Diastolic Cardiac Dysfunction and HFpEF

Study acronym: ARTSPREDICTION
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated May 9, 2024 (before its estimated January 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Start date changed from estimate of Mar 2024 to Feb 23, 2024v5
  2. Trial status: Not Yet Recruiting to Recruitingv4
  3. Start date: Jan 2024 to Mar 2024v3
  4. Secondary endpoints: details revised at 1 of 5 entriesv2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Patients at risk for developing heart failure with preserved ejection fraction (HFpEF) will undergo a structured clinical assessment, transthoracic echocardiography and pulse-wave analysis to investigate the association of arterial stiffening and the development of cardiac diastolic dysfuntion and HFpEF.
Trial Details
NCT Number NCT06208007
Lead Sponsor University Medical Center Goettingen
Conditions Heart Failure With Preserved Ejection Fraction, Cardiovascular Morbidity
Enrollment 150 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov